EWMCX
Price
$39.14
Change
+$0.53 (+1.37%)
Updated
Aug 4 closing price
Net Assets
489.49M
GFACX
Price
$71.68
Change
+$1.40 (+1.99%)
Updated
Aug 4 closing price
Net Assets
319.81B
Interact to see
Advertisement

EWMCX vs GFACX

Header iconEWMCX vs GFACX Comparison
Open Charts EWMCX vs GFACXBanner chart's image
Evercore Equity
Price$39.14
Change+$0.53 (+1.37%)
VolumeN/A
Net Assets489.49M
American Funds Growth Fund of Amer C
Price$71.68
Change+$1.40 (+1.99%)
VolumeN/A
Net Assets319.81B
EWMCX vs GFACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EWMCX vs. GFACX commentary
Aug 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EWMCX is a StrongBuy and GFACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 320B vs. EWMCX (489M). EWMCX pays higher dividends than GFACX: EWMCX (0.39) vs GFACX (0.00). EWMCX was incepted earlier than GFACX: EWMCX (80 years) vs GFACX (24 years). GFACX (1.36) is less costly to investors than EWMCX (0.90). GFACX is a more actively managed with annual turnover of: 25.00 vs. EWMCX (8.55). GFACX has a lower initial minimum investment than EWMCX: GFACX (250) vs EWMCX (1000). GFACX annual gain was more profitable for investors over the last year : 17.12 vs. EWMCX (6.23). EWMCX return over 5 years is better than : 64.56 vs. GFACX (33.36).
EWMCXGFACXEWMCX / GFACX
Total Expense Ratio0.901.3666%
Annual Report Gross Expense Ratio0.901.3666%
Fund Existence80 years24 years-
Gain YTD4.09812.42233%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets489M320B0%
Annual Yield % from dividends0.390.00-
Returns for 1 year6.2317.1236%
Returns for 3 years34.6839.9587%
Returns for 5 years64.5633.36194%
Returns for 10 years167.9768.22246%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEI1.180.02
+1.72%
Alset
CSL358.205.68
+1.61%
Carlisle Companies
INDV21.220.17
+0.81%
Indivior PLC
RYI20.750.11
+0.53%
RYERSON HOLDING Corp
SPRO2.26-0.04
-1.74%
Spero Therapeutics